Cited by 53Coenzyme Q10 studies and effectsLipoproteins and Cardiovascular HealthMuscle Physiology and Disorders

No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy

Open access
Bogsrud, Martin Prøven, Langslet, Gisle, Ose, Leiv, Arnesen, Kjell-Erik, Sm stuen, Milada Cvancarova, Malt, Ulrik Fredrik, Woldseth, Berit, Retterstøl, Kjetil·2013·Scandinavian Cardiovascular Journal

Abstract

OBJECTIVE: The aim of the present study was to evaluate the possible effects of Q10 and selenium supplementation on statin-induced myopathy (SIM), both for subjective symptoms and muscle function. DESIGN: Patients (N = 43) who had experienced previous or ongoing SIM on atorvastatin therapy were recruited. Following a 6-week washout period during which no statins were administered, the patients were re-challenged with 10 mg of atorvastatin. Patients (N = 41) who experienced SIM continued the atorvastatin treatment and were in addition randomized to receive 12 weeks supplement of 400 mg Q10 and 200 μg selenium per day or a matching double placebo. SIM was assessed using 3 validated symptom questionnaires, and a muscle function test was performed at the beginning and at the end of the study. RESULTS: The patients receiving the active supplement experienced significant increases in their serum Q10 and selenium concentrations compared with the group receiving placebo. No statistically significant differences in symptom questionnaire scores or muscle function tests were revealed between the groups. CONCLUSIONS: Despite substantial increases in the serum Q10 and selenium levels following the oral supplementation, this study revealed no significant effects on SIM compared with the placebo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/14017431.2012.756119

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 25 · Cited by 53

Research works printed but not linked: 3

  1. Thompson PD , Clarkson P , Karas RH . Statin-associated 1. myopathy . JAMA. 2003 ; 289 : 1681 -90 .
  2. Quinzii CM , DiMauro S , Hirano M . Human coenzyme Q10 6. defi ciency . Neurochem Res. 2007 ; 32 : 723 -7 .
  3. Br ä hler E , Scheer J . 1983 . Der Giessener Beschwerdebogen 17. (GBB). Bern: Huber . Vassend O , Lian L , Andersen HT . [Norwegian version of 18. NEOPersonality Inventory, Symptom Checklist 90 Revised, and Giessen Subjective Complaints List] . Tidsskr NorP- sykologforen . 1992 ; 29 : 1150 -60 .

Authors
Bogsrud, M. P., Langslet, G., Ose, L., Arnesen, K.-E., Sm stuen, M. C., Malt, U. F., Woldseth, B., & Retterstøl, K.
Affiliations
  • Oslo University Hospital (NO)
  • National Resource Center for Late Effects, Oslo University Hospital, Rikshospitalet, Oslo, Norway
Corresponding author
Bogsrud, Martin Prøven
Venue
Scandinavian Cardiovascular Journal
Published
2013-01-10
Volume
47
Issue
2
Pages
80-87
ISSN
  • 1401-7431 (ISSN-L)
  • 1651-2006
OpenAlex
W1969896801
Cited by
53
References
25
Citations by year
2025: 5 · 2024: 2 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 3 · 2012: 1
FWCI
3.13
Type
journal article
Language
en
Open access
Locations
  • Scandinavian Cardiovascular Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
statin-induced myopathy, atorvastatin, coenzyme Q10, selenium supplementation, statin rechallenge, muscle function, muscle symptoms, statin adverse effects
MeSH terms
Atorvastatin, Adult, Aged, Antioxidants, Double-Blind Method, Drug Therapy, Combination, Female, Heptanoic Acids, Humans, Male, Middle Aged, Muscular Diseases, Prospective Studies, Pyrroles, Surveys and Questionnaires, Selenium, Ubiquinone, Vitamins, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review